However, hopes of leptin therapy for common forms of obesity have not been fulfilled, although recombinant human leptin received approval by the U.S. Food and Drug Administration in 2014 for the treatment of generalized lipodystrophy (7, 24). The gene discussed is LEP; the disease is Obesity.